Urologix (ULGX) Stock Price, Forecast & Analysis
USA - NASDAQ:ULGX -
ULGX Key Statistics, Chart & Performance
The current stock price of ULGX is 0.36 null. In the past month the price decreased by -25%. In the past year, price decreased by -63.27%.
ULGX Latest News, Press Relases and Analysis
About ULGX
Company Profile
Urologix, Inc., based in Minneapolis, develops, manufactures and markets minimally invasive medical products for the treatment of urological disorders. The Company has developed and offers non-surgical, anesthesia-free, catheter-based treatments that use a proprietary cooled microwave technology for the treatment of benign prostatic hyperplasia, a condition that affects more than twenty three million men worldwide. Urologix' products include the CoolWave, Targis and Prostatron control units and the Cooled ThermoCath, Targis and Prostaprobe catheter families. Additionally, Urologix is currently developing CoolMax, its next generation microwave catheter for in-office benign prostatic hyperplasia treatment. All of Urologix' products utilize Cooled ThermoTherapy targeted microwave energy combined with a unique cooling mechanism to protect healthy tissue and enhance patient comfort and provide safe, effective, lasting relief of the symptoms of benign prostatic hyperplasia.
Company Info
Urologix
14405 21ST AVE N
MINNEAPOLIS MN 55447
CEO: Gregory J. Fluet
Phone: 612-475-1400
Urologix / ULGX FAQ
Can you describe the business of Urologix?
Urologix, Inc., based in Minneapolis, develops, manufactures and markets minimally invasive medical products for the treatment of urological disorders. The Company has developed and offers non-surgical, anesthesia-free, catheter-based treatments that use a proprietary cooled microwave technology for the treatment of benign prostatic hyperplasia, a condition that affects more than twenty three million men worldwide. Urologix' products include the CoolWave, Targis and Prostatron control units and the Cooled ThermoCath, Targis and Prostaprobe catheter families. Additionally, Urologix is currently developing CoolMax, its next generation microwave catheter for in-office benign prostatic hyperplasia treatment. All of Urologix' products utilize Cooled ThermoTherapy targeted microwave energy combined with a unique cooling mechanism to protect healthy tissue and enhance patient comfort and provide safe, effective, lasting relief of the symptoms of benign prostatic hyperplasia.
What is the current price of ULGX stock?
The current stock price of ULGX is 0.36 null. The price decreased by -25% in the last trading session.
Does Urologix pay dividends?
ULGX does not pay a dividend.
What is the ChartMill rating of Urologix stock?
ULGX has a ChartMill Technical rating of 0 out of 10.You can find more details on the Technical Analysis and Fundamental Analysis tabs.
ULGX Technical Analysis
ULGX Financial Highlights
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 100% | ||
| ROA | 0% | ||
| ROE | 0% | ||
| Debt/Equity | N/A |